S Bindhya Selected Research

2- methoxy- N- (3- (4- ((3- methyl- 4- ((6- methyl- 3- pyridinyl)oxy)phenyl)amino)- 6- quinazolinyl)- 2- propenyl)acetamide

1/2022

Phosphoproteome of signaling by ErbB2 in ovarian cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Bindhya Research Topics

Disease

2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2021
1	Cardiotoxicity 03/2018
1	Lymphoma (Lymphomas) 03/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2016

Drug/Important Bio-Agent (IBA)

1	PhosphoproteinsIBA 01/2022
1	Lapatinib (GW572016)FDA Link 01/2022
1	2- methoxy- N- (3- (4- ((3- methyl- 4- ((6- methyl- 3- pyridinyl)oxy)phenyl)amino)- 6- quinazolinyl)- 2- propenyl)acetamideIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Daunorubicin (Cerubidine)FDA LinkGeneric 03/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2018
1	Epirubicin (Ellence)FDA LinkGeneric 03/2018
1	AnthracyclinesIBA 03/2018
1	Trastuzumab (Herceptin)FDA Link 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018

Therapy/Procedure

1	Therapeutics 01/2016